An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro

This work illustrates the development of a dry inhalation powder of cyclosporine-A for the prevention of rejection after lung transplantation and for the treatment of COVID-19. The influence of excipients on the spray-dried powder’s critical quality attributes was explored. The best-performing powde...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Davide D’Angelo, Eride Quarta, Stefania Glieca, Giada Varacca, Lisa Flammini, Simona Bertoni, Martina Brandolini, Vittorio Sambri, Laura Grumiro, Giulia Gatti, Giorgio Dirani, Francesca Taddei, Annalisa Bianchera, Fabio Sonvico, Ruggero Bettini, Francesca Buttini
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2023-03-01
Serie:	Pharmaceutics
Soggetti:	cyclosporine-A spray-drying dry powder inhaler SARS-CoV-2 cytokine storm transplant rejection
Accesso online:	https://www.mdpi.com/1999-4923/15/3/1023
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!